• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎对肺血管容量的影响。

Impact of COVID-19 pneumonia on pulmonary vascular volume.

作者信息

Fahrni Guillaume, Rocha Ana-Carolina, Gudmundsson Louis, Pozzessere Chiara, Qanadli Salah D, Rotzinger David C

机构信息

Cardiothoracic and Vascular Division, Department of Diagnostic and Interventional Radiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Riviera Chablais Hospital and University of Lausanne, Lausanne, Switzerland.

出版信息

Front Med (Lausanne). 2023 Mar 22;10:1117151. doi: 10.3389/fmed.2023.1117151. eCollection 2023.

DOI:10.3389/fmed.2023.1117151
PMID:37035332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10073514/
Abstract

BACKGROUND

Pulmonary manifestations of COVID-19 pneumonia are well known. However, COVID-19 is also associated with a range of vascular manifestations such as embolism, congestion, and perfusion changes. Regarding congestion, research from different groups has suggested arteriovenous anastomosis dysregulation as a contributing factor. In this study, we aim to better describe the changes in vascular volume in affected lung zones and to relate them to pathophysiological hypotheses.

METHODS

We performed automatic vascular volume extraction in 10 chest CTs of patients, including 2 female and 8 male with a mean age of 63.5 ± 9.3 years, diagnosed with COVID-19 pneumonia. We compared the proportion of vascular volumes between manually segmented regions of lung parenchyma with and without signs of pneumonia.

RESULTS

The proportion of vascular volume was significantly higher in COVID (CVasc) compared to non-COVID (NCVasc) areas. We found a mean difference (DVasc) of 5% and a mean ratio (RVasc) of 3.7 between the two compartments ( < 0.01).

CONCLUSION

Vascular volume in COVID-19 affected lung parenchyma is augmented relative to normal lung parenchyma, indicating venous congestion and supporting the hypothesis of pre-existing intra-pulmonary arteriovenous shunts.

摘要

背景

新型冠状病毒肺炎(COVID-19)的肺部表现已广为人知。然而,COVID-19还与一系列血管表现相关,如栓塞、充血和灌注改变。关于充血,不同研究团队的研究表明动静脉吻合失调是一个促成因素。在本研究中,我们旨在更好地描述受影响肺区的血管容量变化,并将其与病理生理假设相关联。

方法

我们对10例COVID-19肺炎患者的胸部CT进行了自动血管容量提取,其中包括2名女性和8名男性,平均年龄为63.5±9.3岁。我们比较了有肺炎迹象和无肺炎迹象的肺实质手动分割区域之间的血管容量比例。

结果

与非COVID区域(NCVasc)相比,COVID区域(CVasc)的血管容量比例显著更高。我们发现两个区域之间的平均差异(DVasc)为5%,平均比例(RVasc)为3.7(<0.01)。

结论

COVID-19感染的肺实质中的血管容量相对于正常肺实质增加,表明存在静脉充血,并支持肺内动静脉分流预先存在的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e83/10073514/07fdf6fbb17f/fmed-10-1117151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e83/10073514/ae7abbb1cf68/fmed-10-1117151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e83/10073514/07fdf6fbb17f/fmed-10-1117151-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e83/10073514/ae7abbb1cf68/fmed-10-1117151-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e83/10073514/07fdf6fbb17f/fmed-10-1117151-g002.jpg

相似文献

1
Impact of COVID-19 pneumonia on pulmonary vascular volume.新型冠状病毒肺炎对肺血管容量的影响。
Front Med (Lausanne). 2023 Mar 22;10:1117151. doi: 10.3389/fmed.2023.1117151. eCollection 2023.
2
Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome.COVID-19 致死病例和急性呼吸窘迫综合征中的血管病和血管充血增加。
Am J Respir Crit Care Med. 2022 Oct 1;206(7):857-873. doi: 10.1164/rccm.202109-2150OC.
3
Acute Pulmonary Embolism in COVID-19: A Potential Connection between Venous Congestion and Thrombus Distribution.新型冠状病毒肺炎中的急性肺栓塞:静脉淤血与血栓分布之间的潜在联系
Biomedicines. 2022 Jun 2;10(6):1300. doi: 10.3390/biomedicines10061300.
4
Microvascular injuries, secondary edema, and inconsistencies in lung vascularization between affected and nonaffected pulmonary segments of non-critically ill hospitalized COVID-19 patients presenting with clinical deterioration.非危重症住院 COVID-19 患者在临床恶化时,其肺部受累和未受累节段之间的肺血管化存在差异,表现为微血管损伤、继发性水肿和不一致性。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221096040. doi: 10.1177/17534666221096040.
5
Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series.COVID-19 相关不同肺部病变的通气/灌注 SPECT/CT 表现:病例系列。
Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2453-2460. doi: 10.1007/s00259-020-04920-w. Epub 2020 Jun 18.
6
Clinical and laboratory data, radiological structured report findings and quantitative evaluation of lung involvement on baseline chest CT in COVID-19 patients to predict prognosis.对 COVID-19 患者基线胸部 CT 上的临床和实验室数据、放射学结构化报告结果以及肺部受累的定量评估,以预测其预后。
Radiol Med. 2021 Jan;126(1):29-39. doi: 10.1007/s11547-020-01293-w. Epub 2020 Oct 12.
7
Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.人工智能辅助分析 COVID-19 的临床特征和影像征象。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8210-8218. doi: 10.26355/eurrev_202008_22510.
8
Quantitative determination of pulmonary emphysema in follow-up LD-CTs of patients with COVID-19 infection.定量测定 COVID-19 感染患者 LD-CT 随访中的肺气肿。
PLoS One. 2022 Feb 3;17(2):e0263261. doi: 10.1371/journal.pone.0263261. eCollection 2022.
9
Correlation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) with radiographic features of congestion in chest CT scan of patients with COVID-19.新型冠状病毒肺炎(COVID-19)患者血浆N末端脑钠肽前体(NT-proBNP)与胸部CT扫描充血影像学特征的相关性
Egypt Heart J. 2023 Jul 13;75(1):59. doi: 10.1186/s43044-023-00390-1.
10
CT Features of Coronavirus Disease 2019 (COVID-19) Pneumonia in 62 Patients in Wuhan, China.中国武汉 62 例 2019 年冠状病毒病(COVID-19)肺炎的 CT 特征。
AJR Am J Roentgenol. 2020 Jun;214(6):1287-1294. doi: 10.2214/AJR.20.22975. Epub 2020 Mar 5.

引用本文的文献

1
Commentary: Impact of COVID-19 pneumonia on pulmonary vascular volume.评论:新型冠状病毒肺炎对肺血管容量的影响
Front Med (Lausanne). 2023 Sep 27;10:1223819. doi: 10.3389/fmed.2023.1223819. eCollection 2023.
2
Prognostic value of right ventricular dilatation on computed tomography pulmonary angiogram for predicting adverse clinical events in severe COVID-19 pneumonia.计算机断层扫描肺动脉造影上右心室扩张对预测重症新型冠状病毒肺炎不良临床事件的预后价值
Front Med (Lausanne). 2023 Jul 31;10:1213775. doi: 10.3389/fmed.2023.1213775. eCollection 2023.

本文引用的文献

1
Treatment of COVID-19 Pneumonia and Acute Respiratory Distress With Ramatroban, a Thromboxane A and Prostaglandin D Receptor Antagonist: A Four-Patient Case Series Report.用血栓素A和前列腺素D受体拮抗剂雷马曲班治疗新型冠状病毒肺炎和急性呼吸窘迫:四例病例系列报告
Front Pharmacol. 2022 Jul 22;13:904020. doi: 10.3389/fphar.2022.904020. eCollection 2022.
2
Acute Pulmonary Embolism in COVID-19: A Potential Connection between Venous Congestion and Thrombus Distribution.新型冠状病毒肺炎中的急性肺栓塞:静脉淤血与血栓分布之间的潜在联系
Biomedicines. 2022 Jun 2;10(6):1300. doi: 10.3390/biomedicines10061300.
3
Automated lung vessel segmentation reveals blood vessel volume redistribution in viral pneumonia.
自动化肺血管分割揭示病毒性肺炎中的血管容积再分布。
Eur J Radiol. 2022 May;150:110259. doi: 10.1016/j.ejrad.2022.110259. Epub 2022 Mar 17.
4
Nitric Oxide: The Missing Factor in COVID-19 Severity?一氧化氮:新冠病毒严重程度的缺失因素?
Med Sci (Basel). 2021 Dec 23;10(1):3. doi: 10.3390/medsci10010003.
5
Severe Glutathione Deficiency, Oxidative Stress and Oxidant Damage in Adults Hospitalized with COVID-19: Implications for GlyNAC (Glycine and -Acetylcysteine) Supplementation.新冠病毒肺炎成年住院患者的严重谷胱甘肽缺乏、氧化应激和氧化损伤:对补充甘氨酸-N-乙酰半胱氨酸(GlyNAC)的启示
Antioxidants (Basel). 2021 Dec 27;11(1):50. doi: 10.3390/antiox11010050.
6
The Bronchial Circulation in COVID-19 Pneumonia.新型冠状病毒肺炎中的支气管循环
Am J Respir Crit Care Med. 2022 Jan 1;205(1):121-125. doi: 10.1164/rccm.202103-0594IM.
7
Pulmonary Embolism in Hospitalized Patients with COVID-19: A Multicenter Study.COVID-19 住院患者中的肺栓塞:一项多中心研究。
Radiology. 2021 Dec;301(3):E426-E433. doi: 10.1148/radiol.2021210777. Epub 2021 Jul 13.
8
Low-dose aspirin for early COVID-19: does the early bird catch the worm?低剂量阿司匹林用于早期新冠病毒病:早起的鸟儿有虫吃?
Expert Opin Investig Drugs. 2021 Aug;30(8):785-788. doi: 10.1080/13543784.2021.1950687. Epub 2021 Jul 12.
9
Vasoactive Peptides: Role in COVID-19 Pathogenesis and Potential Use as Biomarkers and Therapeutic Targets.血管活性肽:在 COVID-19 发病机制中的作用及作为生物标志物和治疗靶点的潜在用途。
Arch Med Res. 2021 Nov;52(8):777-787. doi: 10.1016/j.arcmed.2021.05.007. Epub 2021 Jun 5.
10
Pulmonary Vascular Manifestations of COVID-19 Pneumonia.新型冠状病毒肺炎的肺血管表现
Radiol Cardiothorac Imaging. 2020 Jun 18;2(3):e200277. doi: 10.1148/ryct.2020200277. eCollection 2020 Jun.